OrthoPediatrics corp (NASDAQ: KIDS)’s stock price has decreased by -11.18 compared to its previous closing price of 30.95. However, the company has seen a 3.62% increase in its stock price over the last five trading sessions. zacks.com reported 2024-11-06 that The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Is It Worth Investing in OrthoPediatrics corp (NASDAQ: KIDS) Right Now?
The 36-month beta value for KIDS is at 1.19. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for KIDS is 16.35M, and currently, shorts hold a 5.69% of that float. The average trading volume for KIDS on November 08, 2024 was 155.42K shares.
KIDS’s Market Performance
The stock of OrthoPediatrics corp (KIDS) has seen a 3.62% increase in the past week, with a 12.39% rise in the past month, and a 2.16% gain in the past quarter. The volatility ratio for the week is 8.19%, and the volatility levels for the past 30 days are at 5.30% for KIDS. The simple moving average for the past 20 days is 1.65% for KIDS’s stock, with a -5.96% simple moving average for the past 200 days.
Analysts’ Opinion of KIDS
Many brokerage firms have already submitted their reports for KIDS stocks, with Truist repeating the rating for KIDS by listing it as a “Hold.” The predicted price for KIDS in the upcoming period, according to Truist is $31 based on the research report published on January 25, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see KIDS reach a price target of $77, previously predicting the price at $70. The rating they have provided for KIDS stocks is “Buy” according to the report published on June 14th, 2021.
Needham gave a rating of “Buy” to KIDS, setting the target price at $46 in the report published on April 02nd of the previous year.
KIDS Trading at -1.38% from the 50-Day Moving Average
After a stumble in the market that brought KIDS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.12% of loss for the given period.
Volatility was left at 5.30%, however, over the last 30 days, the volatility rate increased by 8.19%, as shares surge +13.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.09% lower at present.
During the last 5 trading sessions, KIDS rose by +3.62%, which changed the moving average for the period of 200-days by -1.61% in comparison to the 20-day moving average, which settled at $27.04. In addition, OrthoPediatrics corp saw -15.44% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KIDS starting from Gerritzen Daniel J, who sale 10,000 shares at the price of $29.30 back on Aug 21 ’24. After this action, Gerritzen Daniel J now owns 77,304 shares of OrthoPediatrics corp, valued at $293,000 using the latest closing price.
Bailey David R, the President and CEO of OrthoPediatrics corp, sale 3,213 shares at $27.59 during a trade that took place back on Mar 11 ’24, which means that Bailey David R is holding 139,384 shares at $88,647 based on the most recent closing price.
Stock Fundamentals for KIDS
Current profitability levels for the company are sitting at:
- -0.16 for the present operating margin
- 0.66 for the gross margin
The net margin for OrthoPediatrics corp stands at -0.14. The total capital return value is set at -0.07. Equity return is now at value -7.63, with -6.17 for asset returns.
Based on OrthoPediatrics corp (KIDS), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -2.16. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -45.39.
Currently, EBITDA for the company is -8.38 million with net debt to EBITDA at 2.6. When we switch over and look at the enterprise to sales, we see a ratio of 3.7. The receivables turnover for the company is 4.17for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.17.
Conclusion
In conclusion, OrthoPediatrics corp (KIDS) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
